Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
11/2003
11/25/2003US6652905 Piezoelectric element and process for production thereof
11/20/2003WO2003095447A1 Process for the preparation of a hydrate of an anthranilic acid derivative
11/20/2003WO2003094919A2 Novel crystalline forms of gatifloxacin
11/20/2003WO2002100860A3 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
11/20/2003WO2002032869A8 Substituted heterocyclic compounds for treating multidrug resistance
11/20/2003WO2002002506A8 Compounds to treat alzheimer's disease
11/20/2003WO2002002505A8 Compounds to treat alzheimer's disease
11/20/2003WO2001085664A8 Compounds and methods for regulating bacterial growth and pathogenesis
11/20/2003US20030216576 Methods for preparing CETP inhibitors
11/20/2003US20030216571 Tricyclic compounds
11/20/2003US20030216569 Viricides; Aids therapy
11/20/2003US20030216568 Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation,compositions and use as medicaments
11/20/2003US20030216429 7-Heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
11/20/2003US20030216428 Sexual disorders; blood disorders; osteoporosis; bone disorders
11/20/2003US20030216409 Heteroaryl alkyl piperazine derivatives
11/20/2003US20030216396 An urea compounds containing a pyridine, quinoline, or isoquinoline functionality, which are useful in the treatment of cancer, inflammation, osteoporosis and angiogenesis
11/20/2003US20030216389 Therapeutic morpholino-substituted compounds
11/20/2003CA2485262A1 Novel crystalline forms of gatifloxacin
11/19/2003EP1362844A1 Benzylamine analogue
11/19/2003EP1362843A2 N-cyclopropyl-2-difluoromethoxy-3-halogenoaniline and intermediate used for production thereof
11/19/2003EP1362039A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1362034A1 Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003EP0991624B1 Phenylalkyl derivatives with thrombin-inhibiting effect
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003EP0809499B1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
11/19/2003CN1128139C New piperazine derivatives and its prepn.
11/18/2003US6649764 Racemization of flusequinan using triphenylphosphine and 10-camphorsulfonyl-oxaziridine to form racemic mixtures
11/18/2003US6649657 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
11/18/2003US6649620 Quinoline and quinazoline compounds useful in therapy
11/18/2003US6649589 Blocking tumor necrosis factor activity with soluble cytokine receptor, monoclonal antibody or tetracycline derivative
11/13/2003WO2003093241A1 Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
11/13/2003WO2003093240A1 Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same
11/13/2003WO2003093239A2 Process for the preparation of quinoline derivatives
11/13/2003WO2003093238A1 Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of macrophage colony stimulating factor receptor
11/13/2003WO2003093237A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors
11/13/2003WO2003092695A1 Bicyclo 4.4.0 antiviral derivatives
11/13/2003WO2003092643A1 Light-protection formulations using acrylonitrile derivatives
11/13/2003WO2003039461A3 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/13/2003WO2003028727A9 3-`hydroxy-(-4-trifluoromethylphenyl)-methyl-7-spirocyclobutyl-5,6,7,8-tetrahydroquinolin-5-ol derivatives and the use of the same as cholesterol ester transfer protein (cetp) inhibitors
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2002096879A9 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
11/13/2003WO2002077609A3 Identification of compounds for the treatment or prevention of proliferative diseases
11/13/2003WO2002032874A8 Substituted heterocyclic compounds for treating multidrug resistance
11/13/2003WO2002032868A8 2-substituted heterocyclic compounds and their use in treating multidrug resistance
11/13/2003WO2002002520A8 Compounds to treat alzheimer's disease
11/13/2003US20030212276 Process for the preparation of 7-substituted-3 quinolinecarbonitriles
11/13/2003US20030212271 Reacting dialkyl malonate ester with trifluoroacetic acid; cyclization, controlling temperature
11/13/2003US20030212101 Respiratory system disorders; antiinflammatory agents; psychological disorders
11/13/2003US20030212100 Antidiabetic agnets; insulin resistance
11/13/2003US20030212097 Osteoporosis, antiarthrtic agents; antitumor agents
11/13/2003CA2484959A1 Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same
11/13/2003CA2483529A1 Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
11/12/2003EP1361215A1 Process for producing quinoline carboxyaldehyde derivative and intermediate thereof
11/12/2003EP1359915A1 Urotensin-ii receptor antagonists
11/12/2003EP1359801A1 Agrochemical compositions with quinoline safeners
11/12/2003EP1242402B1 Novel compounds
11/12/2003EP1115707B1 Benzamide derivatives and ther use as cytokine inhibitors
11/12/2003EP0861243B1 Heterocyclic compounds as bradykinin antagonists
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
11/11/2003US6646137 Non-peptide GnRH agents
11/11/2003US6646012 Central nervous system analgesic; hypotensive agents; antiarrhythmia agents; antidiabetic agents
11/11/2003US6646010 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/11/2003US6646009 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
11/11/2003US6645983 Pharmaceutical compositions comprising 4-quinolones for treating cancers
11/11/2003US6645969 Antiproliferative, anticarcinogenic, and antiinflammatory agents; treatment of leukemia, psoriasis, bone disorders, and atherosclerosis
11/11/2003US6645968 Potassium channel openers
11/11/2003US6645964 1,3,5-Triazine compounds substituted with aromatic N-heterocycle; anticarcinogenic agents
11/11/2003CA2272098C Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
11/11/2003CA2133579C Synergistic composition and process for selective weed control
11/06/2003WO2003091218A1 Method for producing a 7-alkyl-8-hydroxyquinoline by hydrogenation of 7-alkenyl-8 hydroxyquinoline
11/06/2003WO2003090672A2 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
11/06/2003WO2003027132A3 METHOD OF PREPARING 17β-(N-TERT-BUTYLCARBAMOYL)-3-ONE STEROID DERIVATIVES
11/06/2003WO2003000294A8 Pharmaceutical compositions containing a solid dispersion of a poorly-soluble drug in a matrix and a solubility-enhancing polymer
11/06/2003WO2002094799A3 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/06/2003WO2002070509A8 Antagonists of mcp-1 function and methods of use thereof
11/06/2003US20030208072 Process for the manufacture of organic compounds
11/06/2003US20030208069 Method for producing 8-methoxy-quinoline carboxylic acids
11/06/2003US20030207934 Such as ((S)-1-benzyl-2-oxo-but-3-enyl)-carbamic acid tert-butyl ester; for treating human immunodeficiency virus; antimalarial agents
11/06/2003US20030207914 For treatment of tumors and/or cancerous cell growth mediated by raf kinase
11/06/2003US20030207895 Tissue factor antagonists and methods of use thereof
11/06/2003US20030207894 1,4-Disubstituted benzenes as insecticides
11/06/2003US20030207877 Pyridoquinoxaline antivirals
11/06/2003US20030207248 Across biological membranes of living cells; screening test chemicals that modulate a target ion channel; using fluorescence resonance energy transfer (FRET)
11/05/2003EP1358162A1 Dihydroindole and tetrahydroquinoline derivatives
11/05/2003EP1358150A1 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity
11/05/2003EP0902007B1 Chalcone derivatives and drugs containing the same
11/05/2003CN1454203A Substituted nitrated catechols their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
11/05/2003CN1454086A High affinity small molecule C5A receptor modulators
11/05/2003CN1453270A Prepn of quinolone carboxylate
11/04/2003US6642242 Quinoline and quinazoline compounds useful in therapy
11/04/2003US6642223 Benzoheterocyclic derivatives
11/04/2003US6642216 Osteoporosis, periodontal diseases
11/04/2003CA2290709C 2,6-diaminopyridine compounds as intermediates for producing antibacterial dihydropyridone carboxylic acid derivatives
11/04/2003CA2232728C Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components
11/03/2003WO2003092410A1 Method of extracting rutin from buck wheat growed by hydroponics
11/03/2003CA2484403A1 Method of extracting rutin from buck wheat growed by hydroponics
10/2003
10/30/2003WO2003089437A1 A trifluoroacetic acid process to prepare [2,3-b]pyridine intermediates
10/30/2003WO2003032921A3 Treatment of neurodegenerative diseases and cancer of the brain
10/30/2003WO2002069901A3 Cathepsin cysteine protease inhibitors
1 ... 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 ... 277